Skip to main content

Month: May 2023

Skyharbour Resources Engages Marketing Firm

Vancouver, BC, May 15, 2023 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) announces that the Company has entered into a consulting agreement with Marco Messina (“Messina”), a German based communications and media services provider, pursuant to which Messina will provide the Company with investor relations services. The consulting agreement has a term of nine (9) months, unless terminated earlier in accordance with its terms. The investor relations services provided by Messina will be in consulting with the Company’s management in building investor awareness of the Company through Messina’s network in Europe. The Company has agreed to pay Messina a total initial cost of EUR $85,000 upon the commencement of services. Messina is at arm’s length...

Continue reading

Enservco Corporation Reschedules 2023 1st Quarter Earnings Call to Tuesday, May 16, 2023, at 10:00 a.m. Eastern Time

LONGMONT, Colo., May 15, 2023 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries, today announced it has rescheduled its 2023 first quarter earnings call to 10:00 a.m. ET on Tuesday May 16, 2023. The conference call will be accessible by dialing 888-506-0062 (973-528-0011 for international callers). A telephonic replay will be available through May 29, 2023, by calling 877-481-4010 (919-882-2331 for international callers) and entering the Replay ID # 48443. To listen to the webcast, participants should access the Enservco website, located at www.enservco.com, and link to the “Investors” page at least 10 minutes early to register. Participants can also connect directly at https://www.webcaster4.com/Webcast/Page/2228/48443 A...

Continue reading

First Watch Restaurant Group, Inc. Announces Secondary Offering of Common Stock

BRADENTON, Fla., May 15, 2023 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (“FWRG” or the “Company”) (NASDAQ: FWRG), a leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the launch of an underwritten secondary offering (the “Offering”) by certain funds managed by Advent International Corporation (the “Selling Stockholders”) of 3,500,000 shares of the Company’s common stock (“Common Stock”). The underwriter has a 30-day option to purchase up to an additional 525,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The Selling Stockholders will receive all of the proceeds from the Offering. The Company is not selling any shares of Common Stock in the Offering and will not receive any proceeds from the Offering. Jefferies LLC is acting as the...

Continue reading

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data Expected in Mid-2023WARREN, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2023. “We are pleased with the progress we have made to date in 2023, highlighted by the completion of the blinded treatment phase of our ongoing pivotal Phase 3 REBUILD trial,” said Peter Fernandes, Bellerophon’s Chief Executive Officer. “We expect to report top-line results from the study in the middle of this year, a critical milestone for the Company. Importantly, following...

Continue reading

Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ET SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announced financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments. Q1 2023 Corporate Highlights Nasdaq Continued ListingOn February 23, 2023, Adamis announced that Nasdaq had granted its request to extend the period for the Company to regain compliance with the $1 minimum bid share price requirement, subject to the Company evidencing compliance with all applicable criteria for continued listing,...

Continue reading

Onfolio Holdings Inc. Announces First Quarter 2023 Financial Results and Provides Corporate Update

WILMINGTON, Del., May 15, 2023 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (“Onfolio” or the “Company”), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, announces financial results for the first quarter of 2023.  Recent Corporate HighlightsCompleted the acquisition of Contentellect, a provider of software that allows small and midsize businesses to scale their content with blog writing and link building, in February 2023 Appointed:Ravi Jayagopal as CEO of WPFolio, a WordPress plugin development company Tanya Vaughn as CEO of Proofread Anywhere, an online provider of resources for those looking to become professional proofreadersFirst Quarter 2023 Financial HighlightsFirst quarter 2023 revenue grew 250% year-over-year to $1.35...

Continue reading

PainReform Provides Business Update for the First Quarter of 2023

Reports Progress on Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery TEL AVIV, Israel, May 15, 2023 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2023. Ilan Hadar, Chief Executive Officer of PainReform, stated, “We have made significant progress advancing the Phase 3 clinical trial to evaluate PRF-110, our lead drug candidate, for post-surgical pain relief following bunionectomy surgery. Importantly, we announced the completion of treatment for the first part of Phase 3 clinical trial of PRF-110, in which 15 patients undergoing bunionectomy surgery were enrolled at...

Continue reading

Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update

Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants, derivatives or other financial considerations ROCHESTER, N.Y., May 15, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease (NDD) and cancer through the inhibition of SEMA4D today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key programs and financing in the first five months of the year. “Vaccinex continues to make important progress in our clinical programs to develop pepinemab, our proprietary immunotherapy product candidate, to improve patient outcomes in neurodegenerative disease and cancer,” said Maurice Zauderer, Ph.D., President and Chief Executive...

Continue reading

Super League Announces First Quarter Financial Results

Company Fortifies Balance Sheet, Extinguishing All Debt SANTA MONICA, Calif., May 15, 2023 (GLOBE NEWSWIRE) — Super League Gaming (Nasdaq: SLGG), a global leader in building immersive entertainment experiences, has released its first quarter 2023 financial results in the form of a shareholder letter. A webinar hosted by Ann Hand, CEO of Super League, and Clayton Haynes, CFO of Super League, will be streamed here beginning today Monday, May 15, 2023 at 5:00 PM Eastern Time to further discuss the results. Management Commentary by Chief Executive Officer, Ann Hand: “During the first quarter Super League continued to make meaningful strides that significantly improved our position as we look towards the horizon and our $100 million revenue target in 3 years. The next generation internet is upon us, both within gaming and more broadly....

Continue reading

Gulf Resources Reports 1st Quarter 2023 Financial Results

SHOUGUANG, China, May 15, 2023 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced financial results for the three months ended March 31, 2023.Revenues: $9,302,007, representing an increase of 4% over the same period of 2022. The Net Loss was ($557,747) compared to a net loss of ($119,946) for the same period last year.Earnings per share were a loss of $0.05 versus a loss of $0.01 for the same period last year. Cash flow was $4,831,553. Ending cash was $115,771,833. Cash per share $11.10* (based on 10,431,924 shares issued and outstanding.) Net Net Cash $94,872,257, or$9.09 per share. Shareholders’ equity was $274,839,960 or $26.35* per share.Financials...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.